|
MAPK6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.525200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.616000E-01 |
| Normal-vs-Stage2 |
8.455400E-01 |
| Normal-vs-Stage3 |
4.551200E-01 |
| Normal-vs-Stage4 |
8.261000E-01 |
| Stage1-vs-Stage2 |
5.863000E-01 |
| Stage1-vs-Stage3 |
9.876000E-01 |
| Stage1-vs-Stage4 |
5.251000E-01 |
| Stage2-vs-Stage3 |
6.630800E-01 |
| Stage2-vs-Stage4 |
9.976200E-01 |
| Stage3-vs-Stage4 |
6.177400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.265800E-01 |
| Normal-vs-AfricanAmerican |
2.241500E-03 |
| Normal-vs-Asian |
4.133200E-01 |
| Caucasian-vs-AfricanAmerican |
3.560900E-03 |
| Caucasian-vs-Asian |
3.633600E-01 |
| AfricanAmerican-vs-Asian |
1.575990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.510630E-01 |
| Normal-vs-Female |
7.100200E-01 |
| Male-vs-Female |
2.238000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.160030E-01 |
| Normal-vs-Age(41-60Yrs) |
4.282400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.001400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.872400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.095600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.138600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.164600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.750000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.563000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.738000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.155400E-01 |
| Normal-vs-Grade 2 |
5.998000E-01 |
| Normal-vs-Grade 3 |
2.738000E-01 |
| Normal-vs-Grade 4 |
6.806400E-01 |
| Grade 1-vs-Grade 2 |
5.542800E-01 |
| Grade 1-vs-Grade 3 |
3.793400E-01 |
| Grade 1-vs-Grade 4 |
6.117800E-01 |
| Grade 2-vs-Grade 3 |
4.451600E-01 |
| Grade 2-vs-Grade 4 |
9.837000E-01 |
| Grade 3-vs-Grade 4 |
5.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.741600E-01 |
| Normal-vs-ccB subtype |
7.375800E-01 |
| ccA subtype-vs-ccB subtype |
6.214200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.927800E-01 |
| Normal-vs-N1 |
8.368800E-01 |
| N0-vs-N1 |
9.425600E-01 |
|
|
